Concurrent Fusarium chlamydosporum and Microsphaeropsis arundinis infections in a cat

Journal of Feline Medicine and Surgery

Volumn 6, Issue 4, 2004, Pages 271-277

  Kluger, E K ^a   Della Torre, P K ^a   Martin, P ^b   Krockenberger, M B ^b   Malik, R ^b  

^a Kirrawee Veterinary Hospital   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFADROXIL; CLAVULOX; ITRACONAZOLE; KETOCONAZOLE; SILVAZINE; SULFADIAZINE SILVER;

ANIMAL TISSUE; ARTICLE; BIOPSY; CAT DISEASE; CHRONIC INFLAMMATION; CLINICAL FEATURE; COMORBIDITY; DEBRIDEMENT; DRUG RESPONSE; FORELIMB; FUNGUS; FUNGUS CULTURE; FUSARIUM; FUSARIUM CHLAMYDOSPORUM; GRANULOMATOSIS; HINDLIMB; HISTOPATHOLOGY; LIMB AMPUTATION; MALE; METATARSAL BONE; MICROSPHAEROPSIS ARUNDINIS; MYCELIUM; MYCOSIS; NONHUMAN; PROXIMAL INTERPHALANGEAL JOINT; RECURRENT INFECTION; TREATMENT OUTCOME;

ANIMALS; ANTIFUNGAL AGENTS; CAT DISEASES; CATS; DERMATOMYCOSES; DIAGNOSIS, DIFFERENTIAL; FUSARIUM; HINDLIMB; ITRACONAZOLE; KETOCONAZOLE; LACTAMS; MALE; MITOSPORIC FUNGI;

FELIS CATUS; FUNGI; FUSARIUM; FUSARIUM CHLAMYDOSPORUM; MAMMALIA; MICROSPHAEROPSIS;

EID: 3543126006     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2003.08.006     Document Type: Article

References (22)

1. Arikin S. Lozano-Chiu M. Paetznick V. Rex J.H. 2000. In vitro synergy studies with caspofungin and amphotericin B against Aspergillus and Fusarium. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract No. J-932.
2. Boutati E.I. Anaissie E.J. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer centre and implications for management Blood 90 1997 999-1008
3. Cho C.T. Vats T.S. Lowman J.T. Brandsberg J.W. Tosh F.E. Fusarium solani infection during treatment for acute leukemia Journal of Pediatrics 83 1973 1028-1031
4. de Hoog G.S. Guarro J. (Eds.) Atlas of Clinical Fungi 1995 Centraal bureau voor Schimmelcultures Baarn, NL
5. Ellis M.E. Clink H. Younge D. Hainau B. Successful combined surgical and medical treatment of Fusarium infection after bone marrow transplantation Scandinavian Journal of Infectious Diseases 26 1994 225-228
6. Guarro J. Mayayo E. Tapiol J. Aguilar C. Cano J. Microsphaeropsis olivacea as an etiological agent of human skin infection Medical Mycology 37 2 1999 133-137
7. Guarro J. Nucci M. Akiti T. Gene J. Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient Journal of Clinical Microbiology 38 2000 3460-3462
8. Lozano-Chiu M. Arikan S. Paetznick V.L. Anaissie E.J. Loebenberg D. Rex J.H. Treatment of murine fusariosis with SCH56592 Journal of Antimicrobial Agents and Chemotherapy 43 3 1999 589-591
9. Marco F. Pfaller M.A. Messer S.A. Jones R.N. Antifungal activity of a new triazole, voriconazole (UK-109, 496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi Medical Mycology 36 1998 433-436
10. Marlar A.B. Miller P.E. Canton D.D. Scagliotti R. Murphy C.J. Canine keratomycosis: a report of eight cases and literature review Journal of the American Animal Hospital Association 30 1994 331-340
11. Nelson P.E. Dignani M.C. Anaissie E.J. Taxonomy, biology, and clinical aspects of Fusarium species Clinical Microbiology Reviews 7 1994 479-504
12. Pendle S. Weeks K. Kotsiou G. Hudson B. Kluger E. Pritchard R. 2003. Microsphaeropsis arundinis - a plant pathogen causing mammalian tissue infections. International Society of Human and Animal mycoses conference, San Antonio 26th-30th May, 2003.
13. Pereiro M. Jr. Labandeira J. Toribio J. Plantar hyperkeratosis due to Fusarium verticilliodes in a patient with malignancy Clinical and Experimental Dermatology 24 1999 175-178
14. Pujol I. Guarro J. Gene J. Sala J. In vitro antifungal susceptibility of clinical and environmental Fusarium species strains Journal of Antimicrobial Chemotherapy 39 1997 163-167
15. Punnithalingham E. Sphaeropsidales in pure culture from humans Nova Hed 31 1979 119-158
16. Reis A. Sundmacher R. Tintelnot K. Agostini H. Jensen E. Althaus C. Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole British Journal of Ophthalmology 84 2000 932-933
17. Sampathkumar P. Paya C.V. Fusarium infection after solid organ transplantation Clinical Infectious Diseases 32 2001 1237-1240
18. Segal B.H. Walsh T.J. Liu J.M. Wilson J.D. Kwon-Chung K.J. Invasive Infection with Fusarium chlamydosporum in a patient with aplastic anaemia Journal of Clinical Microbiology 36 1998 1772-1776
19. Shah C.V. Jones D.B. Holz E.R. Microsphaeropsis olivacea keratitis and consecutive endophthalmitis American Journal of Ophthalmology 131 1 2001 142-143
20. Sponsel W.E. Graybill J.R. Nevarez H.L. Dang D. Ocular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis British Journal of Ophthalmology 86 7 2002 829-830
21. Sutton B.C. The Coelomycetes 1980 Commonwealth Mycological Institute Kew, UK
22. Vartivarian S.E. Anaissie E.J. Bodey G.P. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management Clinical Infectious Diseases 17 Suppl. 2 1993 S487-S491